In the throes of a "bearish-to-bullish" reversal, the stock exhibits bullish price-volume correlation and impressive relative ...

Eli Casdin, Casdin Capital CEO, joins 'Closing Bell' to discuss the biotech sector, the stocks Casdin favors and much more.

Vir Biotechnology lands a license agreement with Japan’s Astellas Pharma for its lead drug candidate.

If you're looking for a stock that may skyrocket, it's often important to start small. By this, I mean uncovering names that ...

This player's pipeline should keep growth going over the long run.

Raise large amounts of capital with an initial public offering, burn cash while navigating clinical trials, then submit a new ...

Advanced Micro Devices rallies after the chip maker unveils a multi-year deal to supply computing power to Meta Platforms, ...

Grail (GRAL) stock is plummeting after the company's three-year cancer screening trial failed to meet its main goal ...

Sana Biotechnology Inc. (NASDAQ:SANA) is one of the most promising penny stocks under $5 to buy. On February 17, Sana Biotechnology appointed Brian Piper as Executive Vice President and Chief ...